4
Changes in Ownership
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-21-008123
EVP, Corp Strategy & Develop sold 8,735 shares at an average $281.70 ($2,460,615)
- EVP, Corp Strategy & Develop acquired 2,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-02-25 | Option exercise | +2,750 | $88.05 | $242,138 | 19,996 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-02-25 | Sale | −2,012 | $280.75 | $564,877 | 17,984 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-02-25 | Sale | −4,334 | $281.41 | $1,219,643 | 13,650 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-02-25 | Sale | −967 | $282.27 | $272,951 | 12,683 | D |
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-02-25 | Sale | −1,422 | $283.50 | $403,144 | 11,261 | D |
| Derivatives | |||||||
| LaPlume Joseph W EVP, Corp Strategy & Develop | 2021-02-25 | Option exercise · Stock Options (Right to Buy) | −2,750 | 743 | D | ||
| Open-market sales · 8,735 sh · avg $281.70 · $2,460,615 | |||||||
Loading xslF345X03/form4.xml…